Dose-dependent effects of the myosin activator omecamtiv mecarbil on cross-bridge behavior and force generation in failing human myocardium

R Mamidi, J Li, KS Gresham, S Verma… - Circulation: Heart …, 2017 - Am Heart Assoc
Background: Omecamtiv mecarbil (OM) enhances systolic function in vivo by directly binding
the myosin cross-bridges (XBs) in the sarcomere. However, the mechanistic details …

Dose-Dependent Effects of the Myosin Activator Omecamtiv Mecarbil on Cross-Bridge Behavior and Force Generation in Failing Human Myocardium

R Mamidi, J Li, KS Gresham, S Verma, CY Doh… - Circulation: Heart …, 2017 - cir.nii.ac.jp
Dose-Dependent Effects of the Myosin Activator Omecamtiv Mecarbil on Cross-Bridge Behavior
and Force Generation in Failing Human Myocardium | CiNii Research CiNii 国立情報学研究所 …

Dose-Dependent Effects of the Myosin Activator Omecamtiv Mecarbil on Cross-Bridge Behavior and Force Generation in Failing Human Myocardium

R Mamidi, J Li, KS Gresham, S Verma, CY Doh, A Li… - 2017 - Am Heart Assoc
BACKGROUND: Omecamtiv mecarbil (OM) enhances systolic function in vivo by directly
binding the myosin cross-bridges (XBs) in the sarcomere. However, the mechanistic details …

[PDF][PDF] Dose-Dependent Effects of the Myosin Activator Omecamtiv Mecarbil on Cross-Bridge Behavior and Force Generation in Failing Human Myocardium

R Mamidi, J Li, KS Gresham, S Verma, CY Doh, A Li… - 2017 - researchgate.net
BACKGROUND: Omecamtiv mecarbil (OM) enhances systolic function in vivo by directly
binding the myosin cross-bridges (XBs) in the sarcomere. However, the mechanistic details …

Dose-Dependent Effects of the Myosin Activator Omecamtiv Mecarbil on Cross-Bridge Behavior and Force Generation in Failing Human Myocardium

R Mamidi, J Li, KS Gresham, S Verma… - Circulation. Heart …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Omecamtiv mecarbil (OM) enhances systolic function in vivo by directly binding
the myosin cross-bridges (XBs) in the sarcomere. However, the mechanistic details …

Dose-Dependent Effects of the Myosin Activator Omecamtiv Mecarbil on Cross-Bridge Behavior and Force Generation in Failing Human Myocardium

R Mamidi, J Li, KS Gresham, S Verma… - Circulation: Heart …, 2017 - research.torrens.edu.au
Background: Omecamtiv mecarbil (OM) enhances systolic function in vivo by directly binding
the myosin cross-bridges (XBs) in the sarcomere. However, the mechanistic details …

Dose-Dependent Effects of the Myosin Activator Omecamtiv Mecarbil on Cross-Bridge Behavior and Force Generation in Failing Human Myocardium.

R Mamidi, J Li, KS Gresham, S Verma… - Circulation. Heart …, 2017 - europepmc.org
Background Omecamtiv mecarbil (OM) enhances systolic function in vivo by directly binding
the myosin cross-bridges (XBs) in the sarcomere. However, the mechanistic details …

[HTML][HTML] Dose-Dependent Effects of the Myosin Activator Omecamtiv Mecarbil on Cross-Bridge Behavior and Force Generation in Failing Human Myocardium

R Mamidi, J Li, KS Gresham, S Verma… - Circulation. Heart …, 2017 - ncbi.nlm.nih.gov
Background Omecamtiv mecarbil (OM) enhances systolic function in vivo by directly binding
the myosin cross-bridges (XBs) in the sarcomere. However, the mechanistic details …

[PDF][PDF] Dose-Dependent Effects of the Myosin Activator Omecamtiv Mecarbil on Cross-Bridge Behavior and Force Generation in Failing Human Myocardium

R Mamidi, J Li, KS Gresham, S Verma, CY Doh, A Li… - 2017 - researchgate.net
BACKGROUND: Omecamtiv mecarbil (OM) enhances systolic function in vivo by directly
binding the myosin cross-bridges (XBs) in the sarcomere. However, the mechanistic details …